Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$27,000.00

Investigating the effects of syncytin proteins on exosome fusion, cargo delivery, and targeting.

FY 2024-25

Summary
Exosomes (sEVs) are vesicles released by cells that deliver cargo to target cells. sEV targeting is dependent on their composition, which has led to interest in the design of sEVs as therapeutic delivery vehicles. Designer sEVs have shown promise in the delivery of drug treatments for multiple diseases, including cancer and multiple sclerosis. One group of proteins that are studied for sEV design are fusogens, which mediate the fusion of cell membranes depending on specific fusogen receptors. Fusogens are of interest for sEV design as they fuse sEV membranes with cells featuring the receptors, allowing for cell-specific drug delivery. Syncytin 1 and 2 (Syn1 and Syn2) are fusogens found on human sEVs with little research on their roles in sEV design. The receptors required for Syn-mediated membrane fusion are found on tissues of interest for drug delivery, such as the blood-brain barrier, lungs, and cancers. This has led to my desire to investigate the effects of Syn1/Syn2 on therapeutically relevant properties of sEVs. Specifically, I will test how Syn1/Syn2 affect sEV-cell fusion, cargo delivery, and targeting. sEVs featuring either fusogen are expected to have improved fusion and delivery versus controls, and are expected to target cells dependent on the presence of their receptors. Experimentally, cells will be made to produce Syn+ or - sEVs. A fusion assay will compare sEV-cell fusion between groups using flow cytometry. A delivery assay will compare the delivery of sEV cargo to cells using qPCR and western blot. Targeting will be tested using a range of cell types in the fusion and delivery assays, as well as in vivo sEV biodistribution imaging. This study hopes to present syncytins as assets for designing sEVs for the treatment of cell-specific diseases.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
563670
Name
Milley Benjamin P
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the effects of syncytin proteins on exosome fusion, cargo delivery, and targeting.
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Drug Delivery; Endocytosis; Exosome; Fusogen; Membrane Fusion; Rna Interference; Syncytin
Abstract
Exosomes (sEVs) are vesicles released by cells that deliver cargo to target cells. sEV targeting is dependent on their composition, which has led to interest in the design of sEVs as therapeutic delivery vehicles. Designer sEVs have shown promise in the delivery of drug treatments for multiple diseases, including cancer and multiple sclerosis. One group of proteins that are studied for sEV design are fusogens, which mediate the fusion of cell membranes depending on specific fusogen receptors. Fusogens are of interest for sEV design as they fuse sEV membranes with cells featuring the receptors, allowing for cell-specific drug delivery. Syncytin 1 and 2 (Syn1 and Syn2) are fusogens found on human sEVs with little research on their roles in sEV design. The receptors required for Syn-mediated membrane fusion are found on tissues of interest for drug delivery, such as the blood-brain barrier, lungs, and cancers. This has led to my desire to investigate the effects of Syn1/Syn2 on therapeutically relevant properties of sEVs. Specifically, I will test how Syn1/Syn2 affect sEV-cell fusion, cargo delivery, and targeting. sEVs featuring either fusogen are expected to have improved fusion and delivery versus controls, and are expected to target cells dependent on the presence of their receptors. Experimentally, cells will be made to produce Syn+ or - sEVs. A fusion assay will compare sEV-cell fusion between groups using flow cytometry. A delivery assay will compare the delivery of sEV cargo to cells using qPCR and western blot. Targeting will be tested using a range of cell types in the fusion and delivery assays, as well as in vivo sEV biodistribution imaging. This study hopes to present syncytins as assets for designing sEVs for the treatment of cell-specific diseases.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Milley, Benjamin P
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~